Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis

Urothelial bladder cancer (UBC) is a global challenge of public health with limited therapeutic options. Although the emergence of cancer immunotherapy, most notably immune checkpoint inhibitors, represents a major breakthrough in the past decade, many patients still suffer from unsatisfactory clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Jingyu, Ye, Kaiyan, Fei, Yang, Zhang, Ruiyun, Chen, Haige, Zhuang, Guanglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187798/
https://www.ncbi.nlm.nih.gov/pubmed/34123863
http://dx.doi.org/10.3389/fonc.2021.696716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187798/
https://www.ncbi.nlm.nih.gov/pubmed/34123863
http://dx.doi.org/10.3389/fonc.2021.696716

Ejemplares similares